Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7532
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
This text provides information on the cumulative hazard at 15% and 10% for Placebo and Atorvastatin. The hazard ratio (HR) for Atorvastatin is 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. It also presents data on the time to the first primary endpoint through four years of follow-up.*
Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
This text provides data on the percentage of subjects experiencing events under different doses of Atorvastatin (10 mg and 80 mg). The Hazard Ratio (HR) for the occurrence of events is reported as 0.78 (with 95% confidence interval) with a p-value of 0.0002. Additionally, there is information on the time taken to reach the first major cardiovascular endpoint in years.*
Label Image (Lbl500907532)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.